Copyright
©The Author(s) 2018.
World J Diabetes. Oct 15, 2018; 9(10): 172-179
Published online Oct 15, 2018. doi: 10.4239/wjd.v9.i10.172
Published online Oct 15, 2018. doi: 10.4239/wjd.v9.i10.172
Table 1 Study demographics
Mohammadi et al[6] 2017 | Ahmed et al[7] 2017 | Perez-Zabala et al[8] 2016 | Saad et al[9] 2011 | Kakagia et al[10] 2007 | Driver et al[11] 2006 | Li et al[12] 2015 | Saldalam-acchia et al[13] 2004 | Motolese et al[14] 2015 | Shan et al[15] 2013 | Kontopodis et al[16] 2016 | Weighted (mean ± SD)[6] | P-value (PRP vs control) | |
Type of Study | PU | RP | CS | RP | RP | RDBP | RP | RP | PU | PU | RU | N/A | N/A |
Level of evidence | III | II | IV | II | II | II | II | II | III | III | III | N/A | N/A |
No. patients | |||||||||||||
PRP | 70 | 28 | 2 | 12 | 17 | 19 | 59 | 7 | 15 | 21 | 72 | 29.3 ± 25.4 | 0.104 |
Control | N/A | 28 | N/A | 12 | N/A | 21 | 58 | 7 | N/A | N/A | N/A | 25.2 ± 20.0 | |
Age (mean ± SD, yr) | |||||||||||||
PRP | 53.8 ± 10.6 | 43.2 ± 18.2 | 65.5 ± 2.1 | NR | 57.0 ± 12.0 | 58.3 ± 9.7 | 61.4 ± 13.1 | 61.1 ± 9.4 | 52.3 ± 11.3 | 66.5 ± 10.8 | 65 | 58.4 ± 7.2 | 0.678 |
Control | N/A | 49.8 ± 15.4 | N/A | NR | N/A | 55.9 ± 8.1 | 64.1 ± 9.4 | 58.1 ± 7.8 | N/A | N/A | N/A | 58.7 ± 5.9 | |
Female gender, n (%) | |||||||||||||
PRP | 12 (17.1) | 8 (28.6) | 0 (0.0) | NR | NR | 3 (15.8) | 22 (37.3) | 4 (57.1) | 11 (73.3) | 13 (61.9) | 14 (19.4) | 29.70% | 0.407 |
Control | N/A | 10 (35.7) | N/A | NR | N/A | 5 (23.8) | 20 (34.5) | 4 (57.1) | N/A | N/A | N/A | 35.10% | |
Duration of diabetes (mean ± SD, yr) | |||||||||||||
PRP | 16.2 ± 7.9 | NR | 23.5 ± 13.4 | NR | NR | NR | 7.50 | 16.3 ± 7.9 | 38.20 | 6.8 ± 6.7 | NR | 14.1 ± 11.6 | 0.048 |
Control | N/A | NR | N/A | NR | N/A | NR | 10.00 | 19.7 ± 9.9 | N/A | N/A | N/A | 11.0 ± 6.9 | |
Duration of ulcer (mean ± SD, wk) | |||||||||||||
PRP | 19.6 ± 4.7 | 12.5 ± 1.0 | 28.3 ± 9.5 | NR | 19.0 ± 8.0 | NR | 4.28 | NR | NR | 10.1 ± 12.0 | NR | 13.0 ± 8.4 | < 0.001 |
Control | N/A | 11.5 ± 2.8 | N/A | NR | N/A | NR | 3.30 | NR | N/A | N/A | N/A | 6.0 ± 5.8 | |
HbA1c (mean ± SD) | |||||||||||||
PRP | 6.2 ± 0.7 | 7.0 ± 0.5 | 9.4 ± 3.3 | NR | 8.1 ± 2.8 | 7.8 ± 1.5 | 9.8 ± 3.1 | 9.5 ± 1.7 | NR | 9.1 ± 2.2 | NR | 7.9 ± 1.3 | < 0.001 |
Control | N/A | 6.9 ± 0.6 | N/A | NR | N/A | 8.1 ± 1.8 | 9.80 | 8.8 ± 1.7 | N/A | N/A | N/A | 8.7 ± 1.2 | |
Ulcer area (mean ± SD, cm2) | |||||||||||||
PRP | 6.11 ± 4.37 | 6.24 ± 0.9 | 10.25 | NR | 28.4 ± 13.6 | 3.4 ± 4.5 | 4.10 | 27.3 ± 15.6 | 13.92 | 14.0 ± 32.3 | 4.1 ± 3.9 | 7.7 ± 9.3 | < 0.001 |
Control | N/A | 5.72 ± 0.8 | N/A | NR | N/A | 3.6 ± 4.0 | 2.90 | 17.0 ± 8.9 | N/A | N/A | N/A | 4.6 ± 6.6 |
- Citation: Hirase T, Ruff E, Surani S, Ratnani I. Topical application of platelet-rich plasma for diabetic foot ulcers: A systematic review. World J Diabetes 2018; 9(10): 172-179
- URL: https://www.wjgnet.com/1948-9358/full/v9/i10/172.htm
- DOI: https://dx.doi.org/10.4239/wjd.v9.i10.172